VEGF, VEGFR-1 and VEGFR-2 expression in ECs did not vary significantly across all the clinicopathological characteristics analyzed, except for a significant association between tumor grading and VEGF expression in ECs (Table 1). This evidence concerns the gene FLT1 and neoplasm.